Previous 10 | Next 10 |
home / stock / prn:cc / prn:cc news
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, wi...
2024-01-16 16:35:19 ET More on Profound Medical Profound Medical lays out Q4 and FY 2024 preliminary numbers Profound Medical sells 2.67M shares at $7.50 in public offering For further details see: Profound Medical announces $2.94M non-brokered private placement
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (" Profound " or the " Company ") is pleased to announce that the Company has entered into subscription agreements, dated as of January 16, 2024, with certain existing Canadian institutional investors...
2024-01-04 03:31:30 ET More on Profound Medical Profound Medical sells 2.67M shares at $7.50 in public offering Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Seeking Alpha’s Quant Rating on Profound Medical F...
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
2023-12-28 09:54:35 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Profound Medical stock sinks on proposed public offering of common...
2023-12-28 08:51:19 ET Bluejay Diagnostics ( BJDX ) -36% on pricing of $3.5 million stock offering . Cytosorbents CTSO -29% as blood purification system fails key trial . First Wave BioPharma ( FWBI ) -17% . NKGen Biotech ( NKGN ) -12% . ...
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) today announced the pricing of its previously announced underwritten public offering (the “ Offering ”) of 2,666,667 com...
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PRN:CC Stock Symbol:
TSXC Market:
Profound Medical Corp. Website:
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...